Abstract Submission Now Open!
Abstract Submission Closes: 3 June 2020
Abstracts received after this deadline will not be considered.
3 June 2020
2 July - 15 July 2020
Late Breaking Abstracts
Click on the document below to download of the Abstract Poster Specification or Abstract Guidelines, or see below.
MTIS 2020 Abstract Guidelines
MTIS 2020 Meeting Guidelines:
Please read this information carefully before proceeding to the online submission form.
- Epidemiology, comorbidity, outcomes and classification, including big data
- Experimental research
- General aspects of headache care
- Genetics and biomarkers of headache disorders
- Headache pathophysiology: basic science
- Headache pathophysiology: clinical
- Migraine – acute therapy
- Migraine – preventive therapy
- Other primary headache
- Paediatric headache
- Post-traumatic headache
- Psychological and behavioural factors
- Secondary headaches
- Tension-type headache
1. Abstracts can only be submitted online via the online abstract submission form that can be found in the section “ABSTRACTS” on the official 18th Biennial Migraine Trust International Symposium website: http://mtis2020.org/
2. Abstracts must be submitted in English.
3. Abstracts sent by post or email will not be accepted. No exceptions will be made.
- Submitting author: person who submits the abstract
- Presenting author: person who will physically present the abstract at the congress and who is marked as the presenter in the programme. RULES Failure to observe these guidelines may result in disqualification.
1. An abstract can be submitted to the 18th Biennial Migraine Trust International Symposium if it has not been published previously and only presented at a national meeting.
2. The correct topic must be selected to ensure correct scoring. The content of the abstract must be topic related.
3. Abstracts must contain data and meet international ethical standards.
4. Abbreviations should be defined.
5. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
6. An abstract cannot be accepted if the conflict of interest disclosure has not been ticked on the submission form. If the research or one of the co-authors has a conflict of interest, this must be clearly stated.
7. The abstract must contain no more than 3,000 characters to include blank spaces, punctuation as well as authors’ affiliation and titles. (approx. 500 words)
8. The abstract must be structured into the following four sections: -
9. One table can be included, with the following restrictions:-
- Max number of columns: 10
- Max number of rows: 10 Please note that this may significantly reduce the number of available characters.
10. The submitting author will be required to create a user login on the online portal.
11. Abstracts can be saved in ‘DRAFT’ status on the online portal and edited prior to final submission before the deadline of Wednesday 3rd June 2020
11a. Abstracts that meet all criteria must be saved as “FINAL SUBMISSION” to be considered as submitted.
12. You will receive a confirmation number when your abstract has been successfully submitted. If no confirmation number is received, the abstract cannot be considered as successfully submitted and accepted.
14. All data will be lost if you log off the portal without saving the abstract. 15. Please ensure that your abstract does not contain spelling, grammatical or scientific errors as abstracts are reproduced as submitted. Corrections cannot be made after the submission deadline.
16. If you need to withdraw your abstract, please submit a written statement reflecting your reasons to MTIS2020@mci-group.com no later than Monday 27th July 2020.
After The Submission
1. The reviewers will judge the abstracts according to the relevance to MTIS2020. They will assess the standard of English, objectivity of statements, description of the work, suitability of methods to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work and overall impression.
2. The submitting author will be notified by email by the end of June 2020 as to whether the abstract has been accepted. Notifications will be sent to the email address provided on the MTIS online portal, containing the date, time and form of the presentation.
All abstracts accepted for presentation (oral or poster) will be published digitally in the official MTIS abstract book, on the MTIS Event App and in the journal Cephalalgia* The abstracts for the 18th Biennial Migraine Trust International Symposium will also be published online. *Please note that Cephalalgia will retain copyright of all accepted abstracts. PRESENTATION OF ABSTRACTS
1. All accepted abstracts will be presented in poster or oral format.
2. Selected abstracts will, in addition, be invited to present in a moderated poster viewing session held during the Meeting with up to three slides.
3. Poster board space available will be 946mm wide by 2340mm high, the display should not exceed these dimensions. We recommend printing posters to A0 portrait dimensions; A0 portrait – 841mm (w) x 1189mm (h).
4. Please use letters large enough to be easily read at a distance of 1.5 metres with lettering =/> 6mm in height.
5. Personal computers may not be used for presentations. Please bring a copy of your PowerPoint presentation on a USB stick to the Speaker Preview Room at least 4 hours before the start of your presentation session.
If you experience any difficulties or have any questions about submitting an abstract, please contact the abstract management team who are available to help.
General information: MTIS2020@mci-group.com Phone: +44 (0) 1730 715 243